CD274 and neoplasm: Recently, Zhou et al. reported that HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with ccRCC, which is also significantly associated with TILs and suggests that the PFS and OS of tumor patients can be influenced by the tumor immune microenvironment [14].